APO Research

APO RESEARCH · REPORT

Intravenous Therapy (IV) Bottles

Selected research

Market Analysis & Forecast

Global Intravenous Therapy (IV) Bottles Market Analysis and Forecast 2026-2032

Market perspective

The global Intravenous Therapy (IV) Bottles market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Intravenous Therapy (IV) Bottles is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Intravenous Therapy (IV) Bottles is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Intravenous Therapy (IV) Bottles is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Intravenous Therapy (IV) Bottles is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Intravenous Therapy (IV) Bottles include Vioser SA, Technoflex S.A, Sippex, Polycine GmbH, Metrix Company, Medicopack A/S, Kraton Corporation, JW Life Science and JOTOP Glass, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Intravenous Therapy (IV) Bottles, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Intravenous Therapy (IV) Bottles, also provides the sales of main regions and countries. Of the upcoming market potential for Intravenous Therapy (IV) Bottles, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Therapy (IV) Bottles sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Intravenous Therapy (IV) Bottles market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Intravenous Therapy (IV) Bottles sales, projected growth trends, production technology, application and end-user industry.

Intravenous Therapy (IV) Bottles Segment by Company

Vioser SA

Technoflex S.A

Sippex

Polycine GmbH

Metrix Company

Medicopack A/S

Kraton Corporation

JW Life Science

JOTOP Glass

ICU Medical

Fresenius AG

Euro Healthcare Pvt. Ltd.

Baxter Healthcare Limited

Bausch Group

B. Braun

Intravenous Therapy (IV) Bottles Segment by Type

Plastic IV Bottles

Glass IV Bottle

Intravenous Therapy (IV) Bottles Segment by Application

Hospital

Clinic

Others

Intravenous Therapy (IV) Bottles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Therapy (IV) Bottles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Therapy (IV) Bottles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Therapy (IV) Bottles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Intravenous Therapy (IV) Bottles in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Intravenous Therapy (IV) Bottles manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Therapy (IV) Bottles sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intravenous Therapy (IV) Bottles Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Plastic IV Bottles Major Manufacturers Table 3. Glass IV Bottle Major Manufacturers Table 4. Global Intravenous Therapy (IV) Bottles Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Intravenous Therapy (IV) Bottles Industry Trends Table 9. Intravenous Therapy (IV) Bottles Industry Drivers Table 10. Intravenous Therapy (IV) Bottles Industry Opportunities and Challenges Table 11. Intravenous Therapy (IV) Bottles Industry Restraints Table 12. Global Intravenous Therapy (IV) Bottles Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Intravenous Therapy (IV) Bottles Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Intravenous Therapy (IV) Bottles Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2021-2026) Table 16. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2027-2032) Table 17. Global Intravenous Therapy (IV) Bottles Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Intravenous Therapy (IV) Bottles Sales by Region (2021-2026) & (k units) Table 19. Global Intravenous Therapy (IV) Bottles Sales by Region (2027-2032) & (k units) Table 20. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2021-2026) Table 21. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2027-2032) Table 22. Global Intravenous Therapy (IV) Bottles Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Intravenous Therapy (IV) Bottles Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Intravenous Therapy (IV) Bottles Sales Market Share by Manufacturers (2021-2026) Table 26. Global Intravenous Therapy (IV) Bottles Sales Price (USD/unit) of Manufacturers (2021-2026) Table 27. Global Intravenous Therapy (IV) Bottles Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Intravenous Therapy (IV) Bottles Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Intravenous Therapy (IV) Bottles Manufacturers, Product Type & Application Table 30. Global Intravenous Therapy (IV) Bottles Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Intravenous Therapy (IV) Bottles by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Intravenous Therapy (IV) Bottles Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Intravenous Therapy (IV) Bottles Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Intravenous Therapy (IV) Bottles Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2026) Table 37. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2027-2032) Table 38. Global Intravenous Therapy (IV) Bottles Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Intravenous Therapy (IV) Bottles Sales by Type (2021-2026) & (k units) Table 40. Global Intravenous Therapy (IV) Bottles Sales by Type (2027-2032) & (k units) Table 41. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2026) Table 42. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2027-2032) Table 43. Global Intravenous Therapy (IV) Bottles Price by Type (2021-2026) & (USD/unit) Table 44. Global Intravenous Therapy (IV) Bottles Price by Type (2027-2032) & (USD/unit) Table 45. Global Intravenous Therapy (IV) Bottles Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Intravenous Therapy (IV) Bottles Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Intravenous Therapy (IV) Bottles Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2026) Table 49. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2027-2032) Table 50. Global Intravenous Therapy (IV) Bottles Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Intravenous Therapy (IV) Bottles Sales by Application (2021-2026) & (k units) Table 52. Global Intravenous Therapy (IV) Bottles Sales by Application (2027-2032) & (k units) Table 53. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2026) Table 54. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2027-2032) Table 55. Global Intravenous Therapy (IV) Bottles Price by Application (2021-2026) & (USD/unit) Table 56. Global Intravenous Therapy (IV) Bottles Price by Application (2027-2032) & (USD/unit) Table 57. Vioser SA Company Information Table 58. Vioser SA Business Overview Table 59. Vioser SA Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 60. Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio Table 61. Vioser SA Recent Development Table 62. Technoflex S.A Company Information Table 63. Technoflex S.A Business Overview Table 64. Technoflex S.A Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio Table 66. Technoflex S.A Recent Development Table 67. Sippex Company Information Table 68. Sippex Business Overview Table 69. Sippex Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Sippex Intravenous Therapy (IV) Bottles Product Portfolio Table 71. Sippex Recent Development Table 72. Polycine GmbH Company Information Table 73. Polycine GmbH Business Overview Table 74. Polycine GmbH Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio Table 76. Polycine GmbH Recent Development Table 77. Metrix Company Company Information Table 78. Metrix Company Business Overview Table 79. Metrix Company Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio Table 81. Metrix Company Recent Development Table 82. Medicopack A/S Company Information Table 83. Medicopack A/S Business Overview Table 84. Medicopack A/S Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio Table 86. Medicopack A/S Recent Development Table 87. Kraton Corporation Company Information Table 88. Kraton Corporation Business Overview Table 89. Kraton Corporation Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio Table 91. Kraton Corporation Recent Development Table 92. JW Life Science Company Information Table 93. JW Life Science Business Overview Table 94. JW Life Science Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio Table 96. JW Life Science Recent Development Table 97. JOTOP Glass Company Information Table 98. JOTOP Glass Business Overview Table 99. JOTOP Glass Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio Table 101. JOTOP Glass Recent Development Table 102. ICU Medical Company Information Table 103. ICU Medical Business Overview Table 104. ICU Medical Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio Table 106. ICU Medical Recent Development Table 107. Fresenius AG Company Information Table 108. Fresenius AG Business Overview Table 109. Fresenius AG Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio Table 111. Fresenius AG Recent Development Table 112. Euro Healthcare Pvt. Ltd. Company Information Table 113. Euro Healthcare Pvt. Ltd. Business Overview Table 114. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio Table 116. Euro Healthcare Pvt. Ltd. Recent Development Table 117. Baxter Healthcare Limited Company Information Table 118. Baxter Healthcare Limited Business Overview Table 119. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio Table 121. Baxter Healthcare Limited Recent Development Table 122. Bausch Group Company Information Table 123. Bausch Group Business Overview Table 124. Bausch Group Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio Table 126. Bausch Group Recent Development Table 127. B. Braun Company Information Table 128. B. Braun Business Overview Table 129. B. Braun Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. B. Braun Intravenous Therapy (IV) Bottles Product Portfolio Table 131. B. Braun Recent Development Table 132. North America Intravenous Therapy (IV) Bottles Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Intravenous Therapy (IV) Bottles Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Intravenous Therapy (IV) Bottles Sales by Type (2021-2026) & (k units) Table 135. North America Intravenous Therapy (IV) Bottles Sales by Type (2027-2032) & (k units) Table 136. North America Intravenous Therapy (IV) Bottles Sales Price by Type (2021-2026) & (USD/unit) Table 137. North America Intravenous Therapy (IV) Bottles Sales Price by Type (2027-2032) & (USD/unit) Table 138. North America Intravenous Therapy (IV) Bottles Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Intravenous Therapy (IV) Bottles Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Intravenous Therapy (IV) Bottles Sales by Application (2021-2026) & (k units) Table 141. North America Intravenous Therapy (IV) Bottles Sales by Application (2027-2032) & (k units) Table 142. North America Intravenous Therapy (IV) Bottles Sales Price by Application (2021-2026) & (USD/unit) Table 143. North America Intravenous Therapy (IV) Bottles Sales Price by Application (2027-2032) & (USD/unit) Table 144. North America Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Intravenous Therapy (IV) Bottles Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. North America Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 149. North America Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 150. North America Intravenous Therapy (IV) Bottles Sales Price by Country (2021-2026) & (USD/unit) Table 151. North America Intravenous Therapy (IV) Bottles Sales Price by Country (2027-2032) & (USD/unit) Table 152. United States Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 153. Canada Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 154. Mexico Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 155. Europe Intravenous Therapy (IV) Bottles Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Intravenous Therapy (IV) Bottles Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Intravenous Therapy (IV) Bottles Sales by Type (2021-2026) & (k units) Table 158. Europe Intravenous Therapy (IV) Bottles Sales by Type (2027-2032) & (k units) Table 159. Europe Intravenous Therapy (IV) Bottles Sales Price by Type (2021-2026) & (USD/unit) Table 160. Europe Intravenous Therapy (IV) Bottles Sales Price by Type (2027-2032) & (USD/unit) Table 161. Europe Intravenous Therapy (IV) Bottles Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Intravenous Therapy (IV) Bottles Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Intravenous Therapy (IV) Bottles Sales by Application (2021-2026) & (k units) Table 164. Europe Intravenous Therapy (IV) Bottles Sales by Application (2027-2032) & (k units) Table 165. Europe Intravenous Therapy (IV) Bottles Sales Price by Application (2021-2026) & (USD/unit) Table 166. Europe Intravenous Therapy (IV) Bottles Sales Price by Application (2027-2032) & (USD/unit) Table 167. Europe Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Intravenous Therapy (IV) Bottles Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 171. Europe Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 172. Europe Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 173. Europe Intravenous Therapy (IV) Bottles Sales Price by Country (2021-2026) & (USD/unit) Table 174. Europe Intravenous Therapy (IV) Bottles Sales Price by Country (2027-2032) & (USD/unit) Table 175. Germany Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 176. France Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 177. U.K. Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 178. Italy Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 179. Russia Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 180. Spain Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 182. Switzerland Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 183. Sweden Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 184. Poland Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 185. China Intravenous Therapy (IV) Bottles Revenue by Type (2021-2026) & (US$ Million) Table 186. China Intravenous Therapy (IV) Bottles Revenue by Type (2027-2032) & (US$ Million) Table 187. China Intravenous Therapy (IV) Bottles Sales by Type (2021-2026) & (k units) Table 188. China Intravenous Therapy (IV) Bottles Sales by Type (2027-2032) & (k units) Table 189. China Intravenous Therapy (IV) Bottles Sales Price by Type (2021-2026) & (USD/unit) Table 190. China Intravenous Therapy (IV) Bottles Sales Price by Type (2027-2032) & (USD/unit) Table 191. China Intravenous Therapy (IV) Bottles Revenue by Application (2021-2026) & (US$ Million) Table 192. China Intravenous Therapy (IV) Bottles Revenue by Application (2027-2032) & (US$ Million) Table 193. China Intravenous Therapy (IV) Bottles Sales by Application (2021-2026) & (k units) Table 194. China Intravenous Therapy (IV) Bottles Sales by Application (2027-2032) & (k units) Table 195. China Intravenous Therapy (IV) Bottles Sales Price by Application (2021-2026) & (USD/unit) Table 196. China Intravenous Therapy (IV) Bottles Sales Price by Application (2027-2032) & (USD/unit) Table 197. Asia Intravenous Therapy (IV) Bottles Revenue by Type (2021-2026) & (US$ Million) Table 198. Asia Intravenous Therapy (IV) Bottles Revenue by Type (2027-2032) & (US$ Million) Table 199. Asia Intravenous Therapy (IV) Bottles Sales by Type (2021-2026) & (k units) Table 200. Asia Intravenous Therapy (IV) Bottles Sales by Type (2027-2032) & (k units) Table 201. Asia Intravenous Therapy (IV) Bottles Sales Price by Type (2021-2026) & (USD/unit) Table 202. Asia Intravenous Therapy (IV) Bottles Sales Price by Type (2027-2032) & (USD/unit) Table 203. Asia Intravenous Therapy (IV) Bottles Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Intravenous Therapy (IV) Bottles Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Intravenous Therapy (IV) Bottles Sales by Application (2021-2026) & (k units) Table 206. Asia Intravenous Therapy (IV) Bottles Sales by Application (2027-2032) & (k units) Table 207. Asia Intravenous Therapy (IV) Bottles Sales Price by Application (2021-2026) & (USD/unit) Table 208. Asia Intravenous Therapy (IV) Bottles Sales Price by Application (2027-2032) & (USD/unit) Table 209. Asia Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Intravenous Therapy (IV) Bottles Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 213. Asia Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 214. Asia Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 215. Asia Intravenous Therapy (IV) Bottles Sales Price by Country (2021-2026) & (USD/unit) Table 216. Asia Intravenous Therapy (IV) Bottles Sales Price by Country (2027-2032) & (USD/unit) Table 217. Japan Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 218. South Korea Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 219. India Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 220. Australia Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 221. Taiwan Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Intravenous Therapy (IV) Bottles Revenue by Type (2021-2026) & (US$ Million) Table 224. SAMEA Intravenous Therapy (IV) Bottles Revenue by Type (2027-2032) & (US$ Million) Table 225. SAMEA Intravenous Therapy (IV) Bottles Sales by Type (2021-2026) & (k units) Table 226. SAMEA Intravenous Therapy (IV) Bottles Sales by Type (2027-2032) & (k units) Table 227. SAMEA Intravenous Therapy (IV) Bottles Sales Price by Type (2021-2026) & (USD/unit) Table 228. SAMEA Intravenous Therapy (IV) Bottles Sales Price by Type (2027-2032) & (USD/unit) Table 229. SAMEA Intravenous Therapy (IV) Bottles Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Intravenous Therapy (IV) Bottles Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Intravenous Therapy (IV) Bottles Sales by Application (2021-2026) & (k units) Table 232. SAMEA Intravenous Therapy (IV) Bottles Sales by Application (2027-2032) & (k units) Table 233. SAMEA Intravenous Therapy (IV) Bottles Sales Price by Application (2021-2026) & (USD/unit) Table 234. SAMEA Intravenous Therapy (IV) Bottles Sales Price by Application (2027-2032) & (USD/unit) Table 235. SAMEA Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Intravenous Therapy (IV) Bottles Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 239. SAMEA Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 240. SAMEA Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 241. SAMEA Intravenous Therapy (IV) Bottles Sales Price by Country (2021-2026) & (USD/unit) Table 242. SAMEA Intravenous Therapy (IV) Bottles Sales Price by Country (2027-2032) & (USD/unit) Table 243. Brazil Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 244. Argentina Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 245. Chile Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 246. Colombia Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 247. Peru Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 249. Israel Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 250. UAE Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 251. Turkey Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 252. Iran Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 253. Egypt Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Intravenous Therapy (IV) Bottles Distributors List Table 257. Intravenous Therapy (IV) Bottles Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Intravenous Therapy (IV) Bottles Image Figure 2. Global Intravenous Therapy (IV) Bottles Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Therapy (IV) Bottles Market Size Share 2021 VS 2025 VS 2032 Figure 4. Plastic IV Bottles Image Figure 5. Glass IV Bottle Image Figure 6. Global Intravenous Therapy (IV) Bottles Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Intravenous Therapy (IV) Bottles Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Intravenous Therapy (IV) Bottles Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Figure 13. Global Intravenous Therapy (IV) Bottles Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2021-2032) Figure 16. Global Intravenous Therapy (IV) Bottles Sales (2021-2032) & (k units) Figure 17. Global Intravenous Therapy (IV) Bottles Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Intravenous Therapy (IV) Bottles Sales YoY (2021-2032) & (k units) Figure 20. Europe Intravenous Therapy (IV) Bottles Sales YoY (2021-2032) & (k units) Figure 21. China Intravenous Therapy (IV) Bottles Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Intravenous Therapy (IV) Bottles Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Intravenous Therapy (IV) Bottles Sales YoY (2021-2032) & (k units) Figure 24. Global Intravenous Therapy (IV) Bottles Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Intravenous Therapy (IV) Bottles Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Intravenous Therapy (IV) Bottles Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2032) Figure 30. Global Intravenous Therapy (IV) Bottles Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2032) Figure 33. Global Intravenous Therapy (IV) Bottles Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2032) Figure 36. Global Intravenous Therapy (IV) Bottles Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2032) Figure 39. North America Intravenous Therapy (IV) Bottles Revenue Share by Type (2021-2032) Figure 40. North America Intravenous Therapy (IV) Bottles Sales Share by Type (2021-2032) Figure 41. North America Intravenous Therapy (IV) Bottles Revenue Share by Application (2021-2032) Figure 42. North America Intravenous Therapy (IV) Bottles Sales Share by Application (2021-2032) Figure 43. North America Intravenous Therapy (IV) Bottles Revenue Share by Country (2021-2032) Figure 44. North America Intravenous Therapy (IV) Bottles Sales Share by Country (2021-2032) Figure 45. Europe Intravenous Therapy (IV) Bottles Revenue Share by Type (2021-2032) Figure 46. Europe Intravenous Therapy (IV) Bottles Sales Share by Type (2021-2032) Figure 47. Europe Intravenous Therapy (IV) Bottles Revenue Share by Application (2021-2032) Figure 48. Europe Intravenous Therapy (IV) Bottles Sales Share by Application (2021-2032) Figure 49. Europe Intravenous Therapy (IV) Bottles Revenue Share by Country (2021-2032) Figure 50. Europe Intravenous Therapy (IV) Bottles Sales Share by Country (2021-2032) Figure 51. China Intravenous Therapy (IV) Bottles Revenue Share by Type (2021-2032) Figure 52. China Intravenous Therapy (IV) Bottles Sales Share by Type (2021-2032) Figure 53. China Intravenous Therapy (IV) Bottles Revenue Share by Application (2021-2032) Figure 54. China Intravenous Therapy (IV) Bottles Sales Share by Application (2021-2032) Figure 55. Asia Intravenous Therapy (IV) Bottles Revenue Share by Type (2021-2032) Figure 56. Asia Intravenous Therapy (IV) Bottles Sales Share by Type (2021-2032) Figure 57. Asia Intravenous Therapy (IV) Bottles Revenue Share by Application (2021-2032) Figure 58. Asia Intravenous Therapy (IV) Bottles Sales Share by Application (2021-2032) Figure 59. Asia Intravenous Therapy (IV) Bottles Revenue Share by Country (2021-2032) Figure 60. Asia Intravenous Therapy (IV) Bottles Sales Share by Country (2021-2032) Figure 61. SAMEA Intravenous Therapy (IV) Bottles Revenue Share by Type (2021-2032) Figure 62. SAMEA Intravenous Therapy (IV) Bottles Sales Share by Type (2021-2032) Figure 63. SAMEA Intravenous Therapy (IV) Bottles Revenue Share by Application (2021-2032) Figure 64. SAMEA Intravenous Therapy (IV) Bottles Sales Share by Application (2021-2032) Figure 65. SAMEA Intravenous Therapy (IV) Bottles Revenue Share by Country (2021-2032) Figure 66. SAMEA Intravenous Therapy (IV) Bottles Sales Share by Country (2021-2032) Figure 67. Intravenous Therapy (IV) Bottles Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Intravenous Therapy (IV) Bottles Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Plastic IV Bottles
  • Glass IV Bottle
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Vioser SA
  • Technoflex S.A
  • Sippex
  • Polycine GmbH
  • Metrix Company
  • Medicopack A/S
  • Kraton Corporation
  • JW Life Science
  • JOTOP Glass
  • ICU Medical
  • Fresenius AG
  • Euro Healthcare Pvt. Ltd.
  • Baxter Healthcare Limited
  • Bausch Group
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Intravenous Therapy (IV) Bottles Market by Type
  3. 1.2.1 Global Intravenous Therapy (IV) Bottles Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Plastic IV Bottles
  5. 1.2.3 Glass IV Bottle
  6. 1.3 Intravenous Therapy (IV) Bottles Market by Application
  7. 1.3.1 Global Intravenous Therapy (IV) Bottles Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Intravenous Therapy (IV) Bottles Market Dynamics
  1. 2.1 Intravenous Therapy (IV) Bottles Industry Trends
  2. 2.2 Intravenous Therapy (IV) Bottles Industry Drivers
  3. 2.3 Intravenous Therapy (IV) Bottles Industry Opportunities and Challenges
  4. 2.4 Intravenous Therapy (IV) Bottles Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Intravenous Therapy (IV) Bottles Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Intravenous Therapy (IV) Bottles Revenue by Region
  3. 3.2.1 Global Intravenous Therapy (IV) Bottles Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Intravenous Therapy (IV) Bottles Revenue by Region (2021-2026)
  5. 3.2.3 Global Intravenous Therapy (IV) Bottles Revenue by Region (2027-2032)
  6. 3.2.4 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Intravenous Therapy (IV) Bottles Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Intravenous Therapy (IV) Bottles Sales by Region
  9. 3.4.1 Global Intravenous Therapy (IV) Bottles Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Intravenous Therapy (IV) Bottles Sales by Region (2021-2026)
  11. 3.4.3 Global Intravenous Therapy (IV) Bottles Sales by Region (2027-2032)
  12. 3.4.4 Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Intravenous Therapy (IV) Bottles Revenue by Manufacturers
  2. 4.1.1 Global Intravenous Therapy (IV) Bottles Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Intravenous Therapy (IV) Bottles Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Intravenous Therapy (IV) Bottles Sales by Manufacturers
  6. 4.2.1 Global Intravenous Therapy (IV) Bottles Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Intravenous Therapy (IV) Bottles Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Intravenous Therapy (IV) Bottles Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Intravenous Therapy (IV) Bottles Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Intravenous Therapy (IV) Bottles Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Intravenous Therapy (IV) Bottles Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Intravenous Therapy (IV) Bottles Manufacturers, Product Type & Application
  13. 4.7 Global Intravenous Therapy (IV) Bottles Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Intravenous Therapy (IV) Bottles Market CR5 and HHI
  16. 4.8.2 2025 Intravenous Therapy (IV) Bottles Tier 1, Tier 2, and Tier 3
5 Intravenous Therapy (IV) Bottles Market by Type
  1. 5.1 Global Intravenous Therapy (IV) Bottles Revenue by Type
  2. 5.1.1 Global Intravenous Therapy (IV) Bottles Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Intravenous Therapy (IV) Bottles Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Intravenous Therapy (IV) Bottles Sales by Type
  6. 5.2.1 Global Intravenous Therapy (IV) Bottles Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Therapy (IV) Bottles Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2032)
  9. 5.3 Global Intravenous Therapy (IV) Bottles Price by Type
6 Intravenous Therapy (IV) Bottles Market by Application
  1. 6.1 Global Intravenous Therapy (IV) Bottles Revenue by Application
  2. 6.1.1 Global Intravenous Therapy (IV) Bottles Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Intravenous Therapy (IV) Bottles Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Intravenous Therapy (IV) Bottles Sales by Application
  6. 6.2.1 Global Intravenous Therapy (IV) Bottles Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Intravenous Therapy (IV) Bottles Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2032)
  9. 6.3 Global Intravenous Therapy (IV) Bottles Price by Application
7 Company Profiles
  1. 7.1 Vioser SA
  2. 7.1.1 Vioser SA Company Information
  3. 7.1.2 Vioser SA Business Overview
  4. 7.1.3 Vioser SA Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio
  6. 7.1.5 Vioser SA Recent Developments
  7. 7.2 Technoflex S.A
  8. 7.2.1 Technoflex S.A Company Information
  9. 7.2.2 Technoflex S.A Business Overview
  10. 7.2.3 Technoflex S.A Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio
  12. 7.2.5 Technoflex S.A Recent Developments
  13. 7.3 Sippex
  14. 7.3.1 Sippex Company Information
  15. 7.3.2 Sippex Business Overview
  16. 7.3.3 Sippex Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sippex Intravenous Therapy (IV) Bottles Product Portfolio
  18. 7.3.5 Sippex Recent Developments
  19. 7.4 Polycine GmbH
  20. 7.4.1 Polycine GmbH Company Information
  21. 7.4.2 Polycine GmbH Business Overview
  22. 7.4.3 Polycine GmbH Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio
  24. 7.4.5 Polycine GmbH Recent Developments
  25. 7.5 Metrix Company
  26. 7.5.1 Metrix Company Company Information
  27. 7.5.2 Metrix Company Business Overview
  28. 7.5.3 Metrix Company Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio
  30. 7.5.5 Metrix Company Recent Developments
  31. 7.6 Medicopack A/S
  32. 7.6.1 Medicopack A/S Company Information
  33. 7.6.2 Medicopack A/S Business Overview
  34. 7.6.3 Medicopack A/S Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio
  36. 7.6.5 Medicopack A/S Recent Developments
  37. 7.7 Kraton Corporation
  38. 7.7.1 Kraton Corporation Company Information
  39. 7.7.2 Kraton Corporation Business Overview
  40. 7.7.3 Kraton Corporation Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio
  42. 7.7.5 Kraton Corporation Recent Developments
  43. 7.8 JW Life Science
  44. 7.8.1 JW Life Science Company Information
  45. 7.8.2 JW Life Science Business Overview
  46. 7.8.3 JW Life Science Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio
  48. 7.8.5 JW Life Science Recent Developments
  49. 7.9 JOTOP Glass
  50. 7.9.1 JOTOP Glass Company Information
  51. 7.9.2 JOTOP Glass Business Overview
  52. 7.9.3 JOTOP Glass Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio
  54. 7.9.5 JOTOP Glass Recent Developments
  55. 7.10 ICU Medical
  56. 7.10.1 ICU Medical Company Information
  57. 7.10.2 ICU Medical Business Overview
  58. 7.10.3 ICU Medical Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio
  60. 7.10.5 ICU Medical Recent Developments
  61. 7.11 Fresenius AG
  62. 7.11.1 Fresenius AG Company Information
  63. 7.11.2 Fresenius AG Business Overview
  64. 7.11.3 Fresenius AG Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio
  66. 7.11.5 Fresenius AG Recent Developments
  67. 7.12 Euro Healthcare Pvt. Ltd.
  68. 7.12.1 Euro Healthcare Pvt. Ltd. Company Information
  69. 7.12.2 Euro Healthcare Pvt. Ltd. Business Overview
  70. 7.12.3 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio
  72. 7.12.5 Euro Healthcare Pvt. Ltd. Recent Developments
  73. 7.13 Baxter Healthcare Limited
  74. 7.13.1 Baxter Healthcare Limited Company Information
  75. 7.13.2 Baxter Healthcare Limited Business Overview
  76. 7.13.3 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio
  78. 7.13.5 Baxter Healthcare Limited Recent Developments
  79. 7.14 Bausch Group
  80. 7.14.1 Bausch Group Company Information
  81. 7.14.2 Bausch Group Business Overview
  82. 7.14.3 Bausch Group Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio
  84. 7.14.5 Bausch Group Recent Developments
  85. 7.15 B. Braun
  86. 7.15.1 B. Braun Company Information
  87. 7.15.2 B. Braun Business Overview
  88. 7.15.3 B. Braun Intravenous Therapy (IV) Bottles Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 B. Braun Intravenous Therapy (IV) Bottles Product Portfolio
  90. 7.15.5 B. Braun Recent Developments
8 North America
  1. 8.1 North America Intravenous Therapy (IV) Bottles Market Size by Type
  2. 8.1.1 North America Intravenous Therapy (IV) Bottles Revenue by Type (2021-2032)
  3. 8.1.2 North America Intravenous Therapy (IV) Bottles Sales by Type (2021-2032)
  4. 8.1.3 North America Intravenous Therapy (IV) Bottles Price by Type (2021-2032)
  5. 8.2 North America Intravenous Therapy (IV) Bottles Market Size by Application
  6. 8.2.1 North America Intravenous Therapy (IV) Bottles Revenue by Application (2021-2032)
  7. 8.2.2 North America Intravenous Therapy (IV) Bottles Sales by Application (2021-2032)
  8. 8.2.3 North America Intravenous Therapy (IV) Bottles Price by Application (2021-2032)
  9. 8.3 North America Intravenous Therapy (IV) Bottles Market Size by Country
  10. 8.3.1 North America Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Intravenous Therapy (IV) Bottles Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Intravenous Therapy (IV) Bottles Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Intravenous Therapy (IV) Bottles Market Size by Type
  2. 9.1.1 Europe Intravenous Therapy (IV) Bottles Revenue by Type (2021-2032)
  3. 9.1.2 Europe Intravenous Therapy (IV) Bottles Sales by Type (2021-2032)
  4. 9.1.3 Europe Intravenous Therapy (IV) Bottles Price by Type (2021-2032)
  5. 9.2 Europe Intravenous Therapy (IV) Bottles Market Size by Application
  6. 9.2.1 Europe Intravenous Therapy (IV) Bottles Revenue by Application (2021-2032)
  7. 9.2.2 Europe Intravenous Therapy (IV) Bottles Sales by Application (2021-2032)
  8. 9.2.3 Europe Intravenous Therapy (IV) Bottles Price by Application (2021-2032)
  9. 9.3 Europe Intravenous Therapy (IV) Bottles Market Size by Country
  10. 9.3.1 Europe Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Intravenous Therapy (IV) Bottles Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Intravenous Therapy (IV) Bottles Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Intravenous Therapy (IV) Bottles Market Size by Type
  2. 10.1.1 China Intravenous Therapy (IV) Bottles Revenue by Type (2021-2032)
  3. 10.1.2 China Intravenous Therapy (IV) Bottles Sales by Type (2021-2032)
  4. 10.1.3 China Intravenous Therapy (IV) Bottles Price by Type (2021-2032)
  5. 10.2 China Intravenous Therapy (IV) Bottles Market Size by Application
  6. 10.2.1 China Intravenous Therapy (IV) Bottles Revenue by Application (2021-2032)
  7. 10.2.2 China Intravenous Therapy (IV) Bottles Sales by Application (2021-2032)
  8. 10.2.3 China Intravenous Therapy (IV) Bottles Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Intravenous Therapy (IV) Bottles Market Size by Type
  2. 11.1.1 Asia Intravenous Therapy (IV) Bottles Revenue by Type (2021-2032)
  3. 11.1.2 Asia Intravenous Therapy (IV) Bottles Sales by Type (2021-2032)
  4. 11.1.3 Asia Intravenous Therapy (IV) Bottles Price by Type (2021-2032)
  5. 11.2 Asia Intravenous Therapy (IV) Bottles Market Size by Application
  6. 11.2.1 Asia Intravenous Therapy (IV) Bottles Revenue by Application (2021-2032)
  7. 11.2.2 Asia Intravenous Therapy (IV) Bottles Sales by Application (2021-2032)
  8. 11.2.3 Asia Intravenous Therapy (IV) Bottles Price by Application (2021-2032)
  9. 11.3 Asia Intravenous Therapy (IV) Bottles Market Size by Country
  10. 11.3.1 Asia Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Intravenous Therapy (IV) Bottles Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Intravenous Therapy (IV) Bottles Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Intravenous Therapy (IV) Bottles Market Size by Type
  2. 12.1.1 SAMEA Intravenous Therapy (IV) Bottles Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Intravenous Therapy (IV) Bottles Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Intravenous Therapy (IV) Bottles Price by Type (2021-2032)
  5. 12.2 SAMEA Intravenous Therapy (IV) Bottles Market Size by Application
  6. 12.2.1 SAMEA Intravenous Therapy (IV) Bottles Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Intravenous Therapy (IV) Bottles Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Intravenous Therapy (IV) Bottles Price by Application (2021-2032)
  9. 12.3 SAMEA Intravenous Therapy (IV) Bottles Market Size by Country
  10. 12.3.1 SAMEA Intravenous Therapy (IV) Bottles Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Intravenous Therapy (IV) Bottles Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Intravenous Therapy (IV) Bottles Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Intravenous Therapy (IV) Bottles Value Chain Analysis
  2. 13.1.1 Intravenous Therapy (IV) Bottles Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Intravenous Therapy (IV) Bottles Production Mode & Process
  6. 13.2 Intravenous Therapy (IV) Bottles Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Intravenous Therapy (IV) Bottles Distributors
  9. 13.2.3 Intravenous Therapy (IV) Bottles Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research